...
首页> 外文期刊>Research Journal of Applied Sciences: RJAS >Assessment of Obestatin, Ghrelin Hormones Levels and Ghrelin to Obestatin Ratio in Hypertensive Patients
【24h】

Assessment of Obestatin, Ghrelin Hormones Levels and Ghrelin to Obestatin Ratio in Hypertensive Patients

机译:高血压患者的Obestatin,Ghrelin激素水平和Ghrelin与Obestatin比率的评估

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The present study aims to assess ghrelin, obestatin hormones levels and ghrelin to obestatin ratio in patients with hypertension disease and to find out a possible relationship between obestatin, ghrelin level with different criteria including, systolic blood pressure, diastolic blood pressure and Body Mass Index (BMI) in patients with hypertension disease and compared with healthy controls. The 69 patients are diagnosed with hypertension disease (33 males and 36 females) and 20 control healthy subjects (10 males and 10 females) having no history of diabetes mellitus, renal failure and other disease enrolled in this study. The patients are selected from both sexes (males and females) their ages ranged between 40-70 years old. Patients with hypertension disease are recruited from Al-Sader teaching city in Al-Najaf Al-Ashraf Governorate/Iraq. Results of the present study in general revealed a significant increase (p<0.05) in obestatin level in patients with hypertension diseases in a comparison with control group and significant decrease (p<0.05) in ghrelin level in patients with hypertension disease comparing with control group and ratio of ghrelin to obestatin ratio was decreased in patients undergo from hypertension when compared with control group. The result showed a positive correlation among obestatin, systolic pressure, diastolic pressure and Body Mass Index (BMI) with negative correlation between gherlin, systolic pressure, diastolic pressure and negative correlation between ghrelin to obestatin ratio with blood pressure. The present study concluded that ghrelin, obestatin and ghrelin/obestatin ratio might play role in blood pressure regulation.
机译:本研究旨在评估高血压病患者的生长激素释放激素,肥胖抑制素和胃泌素与肥胖抑制素的比率,并找出具有不同标准的肥胖抑制素,生长激素释放激素与收缩压,舒张压和体重指数之间的可能关系(高血压疾病患者中的BMI),并与健康对照组进行比较。 69名患者被诊断出患有高血压疾病(男33例,女36例),有20名对照健康受试者(男10例,女10例)没有糖尿病,肾衰竭和其他疾病的病史。该患者选自年龄在40-70岁之间的男女(男性和女性)。患有高血压疾病的患者是从Al-Najaf Al-Ashraf Governorate /伊拉克的Al-Sader教学城市招募的。总体而言,本研究结果显示,与对照组相比,高血压病患者的肥胖抑制素水平显着提高(p <0.05),而与对照组相比,高血压疾病患者的生长素释放肽水平显着降低(p <0.05)与对照组相比,高血压患者的生长素释放肽与肥胖抑制素之比降低。结果显示,肥胖抑制素,收缩压,舒张压和体重指数(BMI)之间呈正相关,而甘油,收缩压,舒张压与胃泌素与肥胖抑制素比率与血压之间呈负相关。本研究得出结论,生长素释放肽,肥胖抑制素和生长素释放肽/奥贝他汀的比例可能在血压调节中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号